Outcomes of HSV-1 encephalitis infection in glioblastoma: An integrated systematic analysis
- 19 June 2023
- journal article
- research article
- Published by Elsevier in Microbial Pathogenesis
- Vol. 181, 106211
Abstract
No abstract availableKeywords
This publication has 40 references indexed in Scilit:
- A clinical review of treatment outcomes in glioblastoma multiforme—the validation in a non-trial population of the results of a randomised Phase III clinical trial: has a more radical approach improved survival?British Journal of Radiology, 2012
- The molecular basis of herpes simplex virus latencyFEMS Microbiology Reviews, 2012
- Glioblastoma Mimicking Herpes Simplex EncephalitisJournal of Korean Neurosurgical Society, 2011
- Herpes simplex virus induces neural oxidative damage via microglial cell Toll-like receptor-2Journal of Neuroinflammation, 2010
- Intratumoral Hypoxic Gradient Drives Stem Cells Distribution and MGMT Expression in GlioblastomaStem Cells, 2010
- Combined targeting of interleukin‐6 and vascular endothelial growth factor potently inhibits glioma growth and invasivenessInternational Journal of Cancer, 2009
- Sudden progression of a glioblastoma in partial remission?Clinical Neurology and Neurosurgery, 2004
- IL-6 is required for glioma development in a mouse modelOncogene, 2004
- Contamination of glioblastoma multiforme with type 1 herpes simplex virusJournal of Neurosurgery, 2001
- Prominence of the Herpes Simplex Virus Latency-Associated Transcript in Trigeminal Ganglia from Seropositive HumansThe Journal of Infectious Diseases, 1988